AMPH Return on Tangible Equity | Amphastar Pharmaceuticals, Inc.

Amphastar Pharmaceuticals, Inc. (AMPH) Return on Tangible Equity

2026-06-30: Return Tang Equity 52.52%.
2026-03-31: Return Tang Equity 32.61%.
2025-12-31: Return Tang Equity 38.92%.
2025-09-30: Return Tang Equity 47.76%.

Complete source-backed return tang equity history.

Available history: 2012-12-31 to 2026-06-30
Data captured: 2026-09-04

Historical Return Tang Equity

Date	Return Tang Equity
2026-06-30	52.52%
2026-03-31	32.61%
2025-12-31	38.92%
2025-09-30	47.76%
2025-06-30	64.70%
2025-03-31	72.27%
2024-12-31	93.36%
2024-09-30	97.29%
2024-06-30	117.49%
2024-03-31	163.66%
2023-12-31	248.50%
2023-09-30	2698.26%
2023-06-30	-1427.17%
2023-03-31	17.23%
2022-12-31	17.55%
2022-09-30	15.53%
2022-06-30	18.52%
2022-03-31	17.29%
2021-12-31	14.25%
2021-09-30	8.59%
2021-06-30	2.54%
2021-03-31	0.63%
2020-12-31	0.36%
2020-09-30	1.51%
2020-06-30	1.05%
2020-03-31	14.20%
2019-12-31	13.25%
2019-09-30	13.73%
2019-06-30	14.10%
2019-03-31	0.71%
2018-12-31	-1.80%
2018-09-30	-2.23%
2018-06-30	-2.97%
2018-03-31	-1.38%
2017-12-31	1.18%
2017-09-30	-0.16%
2017-06-30	1.04%
2017-03-31	2.66%
2016-12-31	3.19%
2016-09-30	6.80%
2016-06-30	4.74%
2016-03-31	0.13%
2015-12-31	-0.98%
2015-09-30	-4.71%
2015-06-30	-5.56%
2015-03-31	-3.65%
2014-12-31	-3.98%
2014-09-30	-2.36%
2014-06-30	-0.41%

Annual Return Tang Equity

Date	Return Tang Equity
2025-12-31	38.92%
2024-12-31	93.36%
2023-12-31	248.50%
2022-12-31	17.55%
2021-12-31	14.25%
2020-12-31	0.36%
2019-12-31	13.25%
2018-12-31	-1.80%
2017-12-31	1.15%
2016-12-31	3.19%
2015-12-31	-0.98%
2014-12-31	-3.98%
2013-12-31	4.93%
2012-12-31	7.76%

Similar stocks

Stock Name	Country	Market Cap	PE Ratio
Seaport Therapeutics, Inc. (SPTX)	United States	$1.131B
Alto Neuroscience, Inc. (ANRO)	United States	$1.065B	-11.02
MANNKIND CORP (MNKD)	United States	$1.058B	-30.41
Latigo Biotherapeutics, Inc. (LTGO)	United States	$1.176B
Jaguar Health, Inc. (JAGX)	United States	$1.184B
Savara Inc (SVRA)	United States	$1.044B	-9.10
MoonLake Immunotherapeutics (MLTX)	Switzerland	$1.031B	-5.43
Pacira BioSciences, Inc. (PCRX)	United States	$1.020B	69.03
Janux Therapeutics, Inc. (JANX)	United States	$1.019B	-9.15
LB PHARMACEUTICALS INC (LBRX)	United States	$1.220B	-10.87